Barriers to Mental Healthcare Utilization in Parkinson's Disease

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Rutgers, The State University of New Jersey ( University of Medicine and Dentistry New Jersey )
ClinicalTrials.gov Identifier:
NCT01167608
First received: July 20, 2010
Last updated: September 27, 2012
Last verified: September 2012
  Purpose

Parkinson's disease (PD) is the second most common neurodegenerative disorder in the elderly. In most people, the illness is complicated by co-occurring psychiatric problems such as depression and anxiety. These non-motor concerns negatively affect the course and management of the disease, often leading to poor outcomes for both patients and their families. Despite these deleterious consequences, psychiatric symptoms in PD are both underreported by patients as well as under-recognized and under-treated by health care providers.

The primary purpose of this study is to identify and describe barriers to mental healthcare utilization for people with Parkinson's disease. Secondary objectives include the assessment of attitudes and preferences regarding the need for mental health services in the PD community and the acceptability of telehealth interventions as a method for improving access and quality of care. In order to accomplish these aims, participants will be asked to fill out an anonymous survey which will take about 15-30 minutes to complete. To best accommodate PD patients with varying levels of disability, participants will have the option to complete the survey online, on paper, or over the phone. The information obtained from this study will be used to support future treatment development efforts (i.e., phone and internet based interventions, community based trainings with local providers) intended to improve access and quality of mental health care for people with PD. To the best of the investigators knowledge, this is the first study to systematically examine barriers to mental healthcare utilization in PD in a national sample.


Condition Intervention
Parkinson's Disease
Depression
Anxiety
Other: No Intervention. This is a cross-sectional survey study.

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Barriers to Mental Healthcare Utilization in Parkinson's Disease

Resource links provided by NLM:


Further study details as provided by Rutgers, The State University of New Jersey:

Primary Outcome Measures:
  • Survey [ Time Frame: 15 -30 minutes on one day ] [ Designated as safety issue: No ]
    The survey will assess several domains related to mental health care utilization. Participants will report demographic information. Subsequently, if applicable, they will answer questions pertaining to previous use of the mental healthcare system and barriers to future mental healthcare utilization. Attitudes and preferences regarding the need for mental health care services in the PD community, medical history, general healthcare utilization, and the acceptability of telehealth interventions as a method for improving access and quality of care will also be assessed.


Enrollment: 800
Study Start Date: June 2010
Estimated Study Completion Date: March 2013
Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
People with Parkinson's disease Other: No Intervention. This is a cross-sectional survey study.
No intervention.

Detailed Description:

The survey may be completed online at https://www.surveymonkey.com/s/improvecare4pd. Potential participants may also call Dr. Dobkin at 732-235-4051 to complete the survey over the phone or to request a paper copy to mailed out.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

People with Parkinson's disease.

Criteria

Inclusion Criteria:

  • Diagnosis of Parkinson's disease
  • At least 18 years of age

Exclusion Criteria:

  • Less than 18 years of age

We are looking for responses from those who have, as well as those who have not, had mental health treatment in the past.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01167608

Locations
United States, New Jersey
UMDNJ-Robert Wood Johnson Medical School
Piscataway, New Jersey, United States, 08854
Sponsors and Collaborators
University of Medicine and Dentistry New Jersey
Investigators
Principal Investigator: Roseanne D Dobkin, PhD University of Medicine and Dentistry of New Jersey
  More Information

Additional Information:
No publications provided by Rutgers, The State University of New Jersey

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Rutgers, The State University of New Jersey ( University of Medicine and Dentistry New Jersey )
ClinicalTrials.gov Identifier: NCT01167608     History of Changes
Other Study ID Numbers: 0220100120, 1K23NS052155-01A2
Study First Received: July 20, 2010
Last Updated: September 27, 2012
Health Authority: United States: Institutional Review Board
United States: Federal Government

Keywords provided by Rutgers, The State University of New Jersey:
Parkinson's disease
Depression
Anxiety
Treatment

Additional relevant MeSH terms:
Anxiety Disorders
Depression
Depressive Disorder
Parkinson Disease
Mental Disorders
Behavioral Symptoms
Mood Disorders
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases

ClinicalTrials.gov processed this record on April 21, 2014